Europe — EMA
Pamorelin (Triptorelin)
Triptorelin, the active ingredient in Pamorelin, is a Gonadotropin-releasing hormone (GTR) agonist presented as a 0.1 mg/1 ml solution for subcutaneous injection use.
Request sourcing
What is Triptorelin?
Triptorelin, the active ingredient in Pamorelin, is a Gonadotropin-releasing hormone (GTR) agonist presented as a 0.1 mg/1 ml solution for subcutaneous injection use. It is employed in the management of hormone‑dependent conditions such as prostate cancer, endometriosis and uterine fibroids in adults.
GNH USA supplies Pamorelin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Triptorelin used for?
Pamorelin is a GnRH agonist that modulates the hormonal axis in several endocrine‑related conditions. - Prostate cancer: provides androgen suppression to slow tumor progression. - Endometriosis: induces hypo‑estrogenic state to reduce pelvic pain and lesion growth. - Uterine fibroids: creates a low‑estrogen environment that can shrink fibroid size and lessen bleeding. - Assisted reproductive technology (ART) protocols: controls ovarian stimulation timing for improved cycle management.
What are the side effects of Triptorelin?
Adverse reactions to Triptorelin vary with treatment duration and patient characteristics.
Common Side Effects: - Hot flashes - Headache - Injection site pain or erythema - Fatigue - Nausea - Decreased libido
Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiovascular events such as myocardial infarction - Bone mineral density loss leading to osteoporosis - Severe hepatic dysfunction - Acute adrenal insufficiency - Pituitary apoplexy (very rare)
What precautions apply to Triptorelin?
When prescribing Triptorelin, clinicians should consider several safety aspects. - Cardiac monitoring: patients with known cardiovascular disease should be evaluated regularly. - Bone health: assess risk of osteoporosis, especially with long‑term use. - Hormone‑dependent tumor surveillance: monitor for disease progression. - Pregnancy avoidance: effective contraception is required for women of child‑bearing potential. - Drug interactions: review concomitant medications that affect hormone levels. - Store at ambient temperature: keep in original packaging, protect from moisture and light.
What does Triptorelin interact with?
Triptilelin interacts with several drug classes, requiring attention to avoid reduced efficacy or heightened toxicity.
Major Interactions (Avoid): - Combined hormonal contraceptives: may blunt the intended hypo‑estrogenic effect. - Anti‑androgen therapy : interfer ").
Moderate "). - - - - -
